Hospital of Lithuanian University of Health Sciences Kaunas Clinics is the largest and the most advanced medical institution in Lithuania and Baltic States. The entire hospital complex is 160 thousand square meters over an area of 36 hectares.

During the past decade, Hospital of Lithuanian University of Health. Sciences Kaunas Clinics conducted 90 clinical trials. In the 10-year time frame, 90 clinical trials started and 51 clinical trials were completed, i.e. on average, 56.7% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 29 clinical trials were completed. i.e. 96.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital of Lithuanian University of Health. Sciences Kaunas Clinics" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Lithuanian University of Health Sciences" with 12 trials sponsored, "Bayer" with 7 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored and "Takeda" with 7 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital of Lithuanian University of Health. Sciences Kaunas Clinics" #1 collaborator was "Research Council of Lithuania" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Hospital of Lithuanian University of Health. Sciences Kaunas Clinics" are "Ulcerative Colitis" (11 trials), "Crohn Disease" (5 trials), "Crohn's Disease" (5 trials), "Multiple Sclerosis" (5 trials) and "Atrial Fibrillation" (4 trials). Many other conditions were trialed in "Hospital of Lithuanian University of Health. Sciences Kaunas Clinics" in a lesser frequency.

Most popular intervention types in "Hospital of Lithuanian University of Health. Sciences Kaunas Clinics" are "Drug" (114 trials), "Other" (18 trials), "Procedure" (8 trials), "Biological" (5 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Etrolizumab" (4 trials), "Mirikizumab" (4 trials), "Ozanimod" (4 trials) and "Ocrelizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital of Lithuanian University of Health. Sciences Kaunas Clinics" are 127 trials for "All" genders, 9 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital of Lithuanian University of Health. Sciences Kaunas Clinics". undefined are not yet recruiting, 30 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 75 completed trials in Hospital of Lithuanian University of Health. Sciences Kaunas Clinics, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital of Lithuanian University of Health. Sciences Kaunas Clinics, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 10 trials that are defined as “Not Applicable".